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Objective. In the treatment of periodontal defects, composite membranes might be applied
to  protect the injured area and simultaneously stimulate tissue regeneration. This
work  describes the development and characterization of poly(d,l-lactic acid)/Bioglass®
(PDLLA/BG) composite membranes with asymmetric bioactivity. We  hypothesized that the
presence of BG microparticles could enhance structural and osteoconductivity performance
of  pure PDLLA membranes.
Methods. The membranes were prepared by an adjusted solvent casting method that
promoted a non-uniform distribution of the inorganic component along the membrane
thickness. In vitro bioactive behavior (precipitation of an apatite layer upon immersion in
simulated body ﬂuid, SBF), SEM observation, FTIR, swelling, weight loss and mechanical
properties of the developed biomaterials were evaluated. Cell behavior on the membranes
was  assessed using both human bone marrow stromal cells and human periodontal liga-
ment cells.
Results. Just the BG rich face of the composite membranes induced the precipitation of
bone-like apatite in SBF, indicating that this biomaterial exhibit asymmetric osteoconduc-
tive  properties. SEM images, DNA content and metabolic activity quantiﬁcation revealed an
improved cell adhesion and proliferation on the composite membranes. Composite mem-
branes also stimulated cell differentiation, mineralization, and production of extracellular
matrix and calcium nodules, suggesting the positive effect of adding the bioactive micro-particles in the PDLLA matrix.
Signiﬁcance. The results indicate that the proposed asymmetric PDLLA/BG membranes could
have  potential to be used in guided tissue regeneration therapies or in orthopedic applica-
tions, with improved outcomes.©  2013 Academy 
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1.  Introduction
Periodontitis is a disease that destroys the tooth-supporting
tissues, including the alveolar bone, periodontal ligament
(PDL) and cementum. This is the major cause of tooth loss
in human adults [1].  The treatment of periodontal defects can
be a complex process which may require surgery, but as a rule
does not result in surgical intervention. However, periodon-
tal defects, if left empty after open ﬂap debridement, are ﬁlled
with epithelial and ﬁbroblasts, which are the ﬁrst cells to reach
the defect area, generating a core of ﬁbro-epithelial tissues
that does prevent the occurrence of an adequate regeneration
process of the periodontal tissues [2].  In this context, Guided
Tissue Regeneration (GTR) strategies consist in the application
of a membrane that acts as a physical barrier to protect the
defect site, preventing the epithelial cells, ﬁbrous and gingival
connective tissues to reach the injured area. The creation of
segregated space for the invasion of blood vessels and osteo-
progenitor cells protects against the growth of non-osteogenic
tissues. This procedure favors the regeneration of lost and
damaged tissue since it promotes cell repopulation of the peri-
odontal ligament and adjacent alveolar bone. However, acting
solely as physical barriers is a limitation on the clinical effect
of these membranes: they provide no osteoconductive effects,
enabling only minor contributions for new cementum and
bone formation, which, by deﬁnition, is not true periodontal
tissue regeneration [3].  Each side of an implanted membrane
is in contact with a distinct biological environment, in which
the osseointegration should be ideally promoted just in one
of the faces. Nevertheless, this asymmetric bioactive behav-
ior is almost inexistent in currently used GTR membranes
and represents a possible challenge toward the development
of innovative systems for the regeneration of periodontal
tissues. GTR membranes can be obtained from natural or
synthetic materials, either bioabsorbable or nonresorbable.
Degradability is one of the most important requirements for
GTR membranes and intends to avoid second surgical remov-
ing procedure. Natural resorbable collagen membranes have
been widely used, not just because collagen is concretely
one of the components of the alveolar bone and periodon-
tal ligament but also because this material meets almost all
the criteria required [4].  Collagen, however, presents some
drawbacks such as its cytoxicity and xenogenic origin, poor
mechanical strength and fast biodegradation by enzymatic
activity [4,5]. In order to avoid these undesirable characteris-
tics, maintaining the desirable ones, synthetic materials have
been more  frequently used, predominantly those from the
poly(-hydroxyesters) family [6].  The chemical properties of
these polymers allow its hydrolytic degradation and the elim-
ination of the resulting products by natural pathways [7].
Moreover their processing is easy compared to other polymers
and the variety of existent molecular weights and copolymers
permits a wide range of physical, mechanical and degrada-
tion rate related adjustments. Poly(d,l-lactic acid), PDLLA, is
an amorphous polymer, with interesting mechanical proper-
ties and with degradation times in the order of 12–16 months
[8]. It exhibits excellent biocompatibility in vivo, high mechan-
ical stability and the possibility to be combined with drugs
[9–11]. Nevertheless, PDLLA is not osteoconductive. Among9 ( 2 0 1 3 ) 427–436
different strategies that could be used to improve bioactivity
in polymeric systems [12], the combination of osteoconduc-
tive inorganic particles has been widely used [7].  Bioglass® is
a well known bioactive ceramic and has the ability to enhance
the osteoblast activity and attachment between the biomate-
rial and the surrounding bone tissue, possibiliting the bone
growth on the materials surface. Furthermore its dissolution
products can control the gene expression in order to control
the osteogenesis and consequently the production of growth
factors [8],  as well as counteracting the acidic degradation
of the poly(-hydroxyesters) providing a pH buffering effect
[13,14].
In this work, Bioglass® microparticles were compounded
with PDLLA to form a membrane using a solvent casting
methodology. The conditions were optimized for the prepara-
tion of membranes exhibiting preferentially the BG in one of
the sides of the membrane. It is envisioned that, upon implan-
tation, the membrane side richer in BG could be faced to the
defect side in which bone ingrowth should be stimulated while
the more  hydrophobic PDLLA rich side should act mainly as
a barrier to avoid the invasion of soft tissue. Some relevant
properties of the developed membranes were characterized
and their biological performance was assessed, using two  dis-
tinct cell types: human bone marrow stromal cells (hBMSC)
and human periodontal ligament cells (hPDL).
2.  Materials  and  methods
2.1.  Materials
Poly(d,l-lactic acid) (PDLLA), (Mn = 31,750 and Mw = 100,000)
with an inherent viscosity of 1.87 dL/g was purchased from
Purasorb® (PURAC Biochem, The Netherlands) and was used
as received. The 45S5 Bioglass®, with the composition: 45 SiO2,
24.5 CaO, 24.5 Na2O and 6.0 P2O5 in wt%, was supplied by
US Biomaterials Corp. (Florida, USA). The particle size of the
Bioglass® particles (BG), measured by laser scattering analysis
(Coulter LS 100 particle size analyzer, Coulter, USA), was found
to be lower than 20 m.  All the other reagents and solvents
used were of reagent grade and were used without further
puriﬁcation.
2.2. Preparation  of  PDLLA  and  PDLLA/Bioglass®
membranes
All PDLLA membranes were prepared based on a solvent cast-
ing technique. The PDLLA ﬁlms were prepared by dissolving
0.50 g of PDLLA in 30 mL  of chloroform. After total dissolution,
the solution was transferred to a Petri dish with 9 cm of diam-
eter and covered with an aluminum sheet. The Petri dish was
settled in a horizontal position to facilitate the formation of a
cast ﬁlm with uniform thickness. The assembly was kept in a
hood for 24 h, and chloroform was allowed to evaporate at a
very slow rate. Then, the ﬁlms were vacuum dried for 48 h at
40 ◦C.The PDLLA/BG membranes were prepared in the exact
same process as the pure PDLLA membranes. The PDLLA/BG
dispersions were prepared by dissolving 0.40 g of PDLLA in
30 mL of chloroform. After total dissolution, 0.10 g of Bioglass®
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as dispersed in the above solution. During solvent evapora-
ion the particles were deposited by gravity to the bottom side,
reating an asymmetric of 80/20 PDLLA/BG membrane along
he thickness.
.3. Bioactivity  tests
or the in vitro bioactivity tests an acellular simulated body
uid (SBF) (1.0×) with ions concentration nearly equal to
uman blood plasma was prepared [15]. Sample membranes
f 20 ×15 mm2 were cut from the original processed ﬁlms for
he bioactivity tests. Three replicates for each sample were
mmersed in 45 mL  SBF for 2, 5, 7, 14 and 21 days at 37 ◦C.
fter being removed from SBF the membranes were gently
insed with distilled water and dried at room temperature.
.4.  Physico-chemical  characterization
.4.1.  Scanning  Electron  Microscopy  (SEM)
ualitative information of the morphology of PDLLA and
DLLA/BG membranes surfaces, before and after the immer-
ion in SBF, was obtained using a Scanning Electron
icroscope, SEM (Nova NanoSEM 200-FEI Company, USA), at
n accelerated voltage of 5 kV. Before being observed by SEM,
he membranes were gold coated.
.4.2.  Fourier  Transform  Infrared  Spectroscopy  (FTIR)
he chemical structure of each side of the composite mem-
rane were analyzed using FTIR. Spectra were recorded in an
R Prestige 21 FTIR spectrophotometer (Shimadzu, Japan) with
he attenuated total reﬂection accessory (128 scans, resolution
 cm−1) in the spectral range 2000–400 cm−1.
.5.  Mechanical  characterization
he tensile properties were determined using an INSTRON
505 Universal Machine (Instron Int. Ltd., USA) equipped with
 1 kN load cell, with a loading rate of 5 mm  min−1, up to
0% of strain, at room temperature. Samples were analyzed
n dry and wet conditions. For the wet  condition, samples
ere immersed for 3 h in PBS before being tested. The values
eported represent an average of at least ﬁve testing speci-
ens. Tensile stress was taken as the maximum stress in the
tress-strain curve. Tensile modulus was estimated from the
nitial linear section of the stress-strain curve.
.6.  Cell  culture  studies  using  hBMSC  and  hPDL
wo types of cells were used in this study, namely human
eriodontal ligament cells (hPDL) and human bone marrow
tromal cells (hBMSC). Both cells types were collected from
wo different donors.
hPDL were obtained from human third molar according
o the following procedure. After extraction, the teeth were
ashed three times for 10 min  in PBS with 100 units/mL peni-
illin and streptomycin. PDL tissue was scraped from the
iddle third of the root with a scalpel blade, to avoid con-
amination by epithelial or pulpal cells. The freed portions
f the periodontal ligament were minced and transferred
o a small culture ﬂask, ﬁlled with 5 mL  alpha minimal( 2 0 1 3 ) 427–436 429
essential medium (-MEM, Gibco) with 10% (v/v) fetal calf
serum (FCS, Gibco), 50 mg/mL  ascorbic acid (Sigma), 10-8 M
dexamethasone (Sigma), 50 mg/mL  gentamycin (Gibco) and
10 mM sodium -glycerophosphate (Sigma). Cells were cul-
tured at 37 ◦C in a humidiﬁed atmosphere of 5% CO2 and
medium was replaced every 2–3 days. Upon reaching conﬂu-
ence, cells were released with trypsin/EDTA (0.25%, (w/v) crude
trypsin and 1 mM EDTA, pH 7.2) and sub-cultured for two  pas-
sages in standard culture ﬂasks. The cells were then frozen in
liquid nitrogen until used for the experiments.
Human BMSC were isolated from bone blocks of human
iliac crest biopsies of donors. The biopsies were discarded tis-
sues during standard surgical procedures at Radboud Univer-
sity Nijmegen Medical Center (Nijmegen, The Netherlands).
The bone blocks were cut into small pieces and subsequently
placed in a 50 mL  tube to which 20 mL alpha-minimal essen-
tial medium (-MEM)  was added. After that the tube was
shaken vigorously and the medium with cells was collected.
This procedure was repeated several times. The collected
medium with cells was plated in culture ﬂasks (T175, Greiner
Bio-one) and expanded in proliferation medium. Cells were
characterized and showed stem cells phenotype. Additionally,
a multipotential differentiation test was applied, demonstrat-
ing their stem cells capacity. Cells were cultured at 37 ◦C in
a humid atmosphere with 5% CO2 and its passage was per-
formed at 80% conﬂuence using trypsin EDTA (Gibco).
Speciﬁc culture medium (O−) was used for each cell type.
The hPDL O− was composed of -MEM (Gibco) with 10%
fetal bovine serum (FBS, Greiner Bio-one) and 100 units mL−1
penicillin/streptomycin (Gibco). The hBMSC O− was com-
posed of -MEM (Gibco) with 15% FBS (Greiner Bio-one), 1%
l-glutamine, 1% ascorbic acid (Sigma), 100 units mL−1 peni-
cillin/streptomycin (Gibco) and 1%, by volume added to each
cell culture ﬂask, basic ﬁbroblast growth factor (bFGF). After
the ﬁrst generation, cells were plated at a density of 5000
cells/cm2 in culture ﬂasks (T175, Greiner Bio-one). The cul-
ture medium was changed twice a week. Cells from passage 3
(hBMSC) and 5 (hPDL) were used in the biological experiments.
All Gibco products are from Life Technologies BV, Breda, the
Netherlands, all Greiner Bio-one products from Greiner Bio-
one BV, Alphen aan de Rijn, the Netherlands, and all Sigma
products from Sigma–Aldrich Chemie B.V., Zwijndrecht, the
Netherlands.
2.6.1.  Cell  seeding
Metal rings (15 mm diameter × 3 mm thickness) were glued
to the membrane with RTV silicone adhesive (Nusil Tech-
nology, Carpinteria, CA), to keep them in the bottom of the
culture well, preventing ﬂuctuation. Prior to cell seeding, the
samples were sterilized with 70% (v/v) ethanol for 60 min
and then washed three times immersed in PBS. The sam-
ples were placed in 25-well plates and soaked in cell culture
medium overnight. After removing the culture medium, 50 L
of a cell suspension with a 2.0 × 104/sample cell density, was
seeded onto the surface of each sample. After incubation for
4 h at 37 ◦C in a 5% CO2 atmosphere incubator, osteogenic
medium (referred as O+), speciﬁc for each cell type, was
added to the seeded samples, according to the type of assay
performed. The hPDL O+ was composed of -MEM (Gibco)
with 10% FBS (Greiner Bio-one), 1% ascorbic acid (Sigma), 1%
l s 2 430  d e n t a l m a t e r i a 
b-glycerophosphate (Sigma), 1% dexamethasone (Sigma) and
100 units mL−1 penicillin/streptomycin (Gibco). The hBMSC
O+ was composed of a-MEM (Gibco) with 15% FBS (Greiner
Bio-one), 1% l-glutamine, 1% ascorbic acid (Sigma), 1% b-
glycerophosphate (Sigma), 1% dexamethasone (Sigma) and
100 units mL−1 penicillin/streptomycin (Gibco). On the con-
trol groups, cells were seeded directly on the well-plates and
osteogenic medium was added immediately.
2.7.  Cell  adhesion,  proliferation  and  metabolic  activity
2.7.1. DNA  content
After the different experimental time points, medium was
removed from the wells and the samples were washed twice
with PBS. The analysis was performed on the supernatant of
the substrates after day 1, 3, 7, 14 and 28 of culture. Cells were
lysed using milliQ with subsequent soniﬁcation for 10 min
between two cycles of freeze/thaw from −80 ◦C. The super-
natant was stored at −20 ◦C until further analysis. A PicoGreen
dsDNA Quantiﬁcation Kit (Molecular Probes, Eugene, USA) was
used according to manufacturer’s instructions. To each 100 L
sample, 100 L PicoGreen working solution was added. The
samples must incubate for 2–5 min  at room temperature, in
the dark. After incubation, the ﬂuorescence was measured on
a ﬂuorescence cuvette reader (microplate ﬂuorescence reader,
Bio-Tek, Winooski, USA) with a 485 nm excitation ﬁlter and a
530 nm emission ﬁlter.
2.7.2.  AlamarBlue® staining
Cell metabolic activity was measured using AlamarBlue®
staining (Invitrogen) according to the instructions of the man-
ufacturer. A solution was made with AlamarBlue and culture
medium in a proportion 1:9 (v/v) and was placed at 37 ◦C for
5 min. The medium was removed from wells and replaced
with the solution. Plates were incubated (37 ◦C and 5% CO2)
for 4 h. After incubation, 200 L of each sample solution was
transferred to 96-well plates (Greiner Bio-one). Fluorescence
was measured using a microplate reader (FL 600; Bio-Tek) at
570 nm.  The assay was performed on day 1, 3, 7, 14 and 28 of
culture.
2.7.3.  Scanning  Electron  Microscopy  (SEM)  observation
Adhesion of both cell types (hBMSC and hPDL) on membranes
was analyzed by SEM (n = 2). After day 3 and day 28 time points,
cells were ﬁxed in 2% (v/v) glutaraldehyde in 0.1 M sodium-
cacodylate buffered solution, for 5 min. Cells were rinsed in
cacodylate buffered solution, dehydrated in a series of ethanol
dilutions in water (70%, 80%, 90%, 96% and 100% (v/v)), 1 h
in each, and dried in tetramethylsilane (TMS, Merck) to air.
Finally, specimens were sputtercoated with a thin layer of gold,
and examined in a JEOL 6310 scanning electron microscope.
2.8.  Cell  differentiation  and  mineralization
2.8.1.  Alkaline  Phosphatase  activity  measurements  (ALP)
The same supernatants as used for PicoGreen assay were also
used to measure alkaline phosphatase (ALP) activity (Sigma).
To each 80 L of sample, 20 L of 0.5 M Alkaline Buffer (Sigma)
was added. Thereafter 100 L substrate solution 5 mM paran-
itrophenylphosphate (PNP, Sigma) was added to each well.9 ( 2 0 1 3 ) 427–436
After 60 min  of incubation at 37 ◦C, 100 L stop solution (0.3 M
NaOH) was added to each well. Finally, ALP activity was mea-
sured at 405 nm using an ELISA microplate reader (Bio-Tek
Instruments Inc, USA).
2.8.2. Von  Kossa  staining
Cells were ﬁxed with 2% glutaraldehyde, stained with fresh 5%
silver nitrate (AgNO3), washed with distilled water, developed
with 5% sodium carbonate (Na2CO3) in 25% formalin, and ﬁxed
with 5% sodium thiosulphate (Na2S2O3). Stained samples were
observed under a Leica MZ12 stereomicroscope and images
were captured.
2.8.3.  Calcium  content
Calcium content was assessed after 21 and 28 days of culture
to obtain information about mineralized matrix formation.
The samples were rinsed twice with milliQ. 1 mL  of acetic
acid was added to each sample. The samples were incubated
overnight under vigorous constant shaking and the acetic acid
with the diluted calcium was frozen and kept at −20 ◦C, until
further investigation. After thawing, the calcium content was
determined using the OCPC method. Optic density was read
with an ELISA reader (Bio-Tek Instruments Inc, USA) at a wave-
length of 570 nm.  Bare membranes were also assessed in order
to further exactly quantify and distinguish cellular from acel-
lular mineralization on the membranes.
2.9.  Statistical  analysis
All samples were measured in triplicate. Biological tests were
performed twice, excepting Von Kossa. All results are pre-
sented as mean ± standard deviation. Statistical analysis of
experimental data was performed using an unpaired ordinary
ANOVA with standard parametric methods. Calculations were
performed in InStat (v. 3.0 GraphPad Software Inc, San Diego,
CA). Statistical signiﬁcance was set to p-value ≤ 0.1 (*), to p-
value ≤ 0.01 (**) and to p-value ≤ 0.001 (***).
3.  Results
3.1.  Membranes  characterization
3.1.1. Bioactivity,  morphology  and  microstructure
The surface morphology of PDLLA and PDLLA/BG membranes
was analyzed using SEM – see Fig. 1a. A ﬂat, smooth, non-
porous surface was observed on the PDLLA membranes with
no evidence of surface irregularity (A1). Both upper and bot-
tom faces of the composite membrane (see scheme in Fig. 1b)
were also analyzed. The upper face of the composite PDLLA/BG
80/20 membrane is also smooth (B1) but the bottom face (C1)
presents some asperities, homogeneously distributed in the
surface corresponding to the BG particles that were prefer-
entially deposited in this side of the membrane. The image
suggests that the particles are well incorporated in the poly-
meric matrix.The bioactive character of the produced composite mem-
branes was tested in vitro by immersing the materials in SBF
– see evolution of the morphology of the surfaces in Fig. 1a.
No Ca–P layer was formed on the surface of pure PDLLA
d e n t a l m a t e r i a l s 2 9 ( 2 0 1 3 ) 427–436 431
Fig. 1 – In vitro bioactivity tests of the developed membranes: (a) SEM micrographs of the surfaces of the PDLLA (A1) and
PDLLA/BG membranes, from upper and bottom face (B1 and C1), before and after 2 days of immersion in SBF (A2, B2, and C2).
The scale bar represents 50 m.  (b) Schematic design of the PDLLA/BG membrane and respective SEM image, evidencing the
distinct faces. (c) FT-IR spectra of both sides of the composite membrane: bottom face rich in BG (dark gray line) and upper
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3.2.1.  Cell  adhesion,  proliferation  and  metabolic  activity
DNA content was quantiﬁed at different culture time points
for both membranes – see Fig. 3a. A clear proliferation oface exposing basically PDLLA (light gray line).
embrane (A2) or on the upper face of the composite mem-
rane (B2), even after 21 days of immersion in SBF. Only the
embranes face enriched with BG presented a bioactive char-
cter, where an uniform ceramic layer could be detected after
nly 2 days of immersion in SBF (C2).
The morphological analysis was complemented with FTIR
 see Fig. 1c. The characteristic FTIR bands of the upper face are
ocated at 750 and 865 cm−1 (CH band); 1042, 1090, 1138, and
186 cm−1 ( C O stretch); 1375 cm−1 (CH2 wag); 1452 cm−1
CH3 band) and 1751 cm−1 (C O stretch, ester group) that are
he characteristic bands of PDLLA [16]. The spectrum of the
ottom face of the membrane indicates the presence of BG par-
icles: 867, 1454 cm−1 (CO32− bands); 1200–700 cm−1 (Si O Si
ands) [17,18].
In order to understand the behavior of the membranes in
n aqueous environment, the weight loss and swelling ratio
ere measured up to 4 months.
In the system studied in this work, no signiﬁcant swelling
as observed in the membranes even when BG is incorpo-
ated (data not shown). Within the time period analyzed the
eight loss of the PDLLA membrane was not signiﬁcant: after
20 days of immersion in PBS, the weight loss was about 12%.
or the case of the composite membrane we could detect a
aster weight loss up to 50 days (data not shown), that could
e explained by the partial dissolution of the inorganic com-
onent..1.2. Mechanical  properties
ensile mechanical tests were performed for the PDLLA and
DLLA/BG membranes. Both dry and wet specimen condi-
ions were assessed; the last condition simulates better thebehavior of these materials in the oral cavity environment.
Representative stress-strain curves are shown in Fig. 2. Table 1
shows the maximum strain and stress obtained in these
experiments as well as the tensile or Young modulus of the
membranes. The addition of BG in the PDLLA membranes sig-
niﬁcantly reduced the maximum strain and a small reduction
of the maximum stress could also be detected. Young modulus
values were very similar between both types of membranes,
in both dry and wet conditions.
3.2.  In  vitro  hBMSC  and  hPDL  cultureFig. 2 – Representative stress versus strain curves obtained
for PDLLA and PDLLA/BG membranes in dry (solid lines)
and wet (dashed lines) conditions.
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Table 1 – Young modulus, maximum strain and maximum stress of the PDLLA and PDLLA/BG membranes obtained in
dry and wet conditions. Values are reported as mean ± SD.
Condition Young modulus (Mpa) Maximum strain (%) Maximum stress (Mpa)
Dry Wet Dry Wet Dry Wet
PDLLA 713.7 ± 77.9 656.9 ± 38.1 166.2 ± 81.3 141.0 ± 94.1 26.2 ± 1.56 27.4 ± 1.38
PDLLA/BG 743.3 ± 30.3 617.9 ± 38.8 21.9 ± 5.5* 21.6 ± 11.4* 17.7 ± 5.21** 23.1 ± 1.43
∗ Statistically signiﬁcant differences in the mechanical properties of the PDLLA/BG membranes when compared to those of the pure PDLLA for
p < 0.1.
∗∗ Statistically signiﬁcant differences in the mechanical properties of the PDLLA/BG membranes when compared to those of the pure PDLLA forp < 0.01.
both cell types onto the PDLLA and PDLLA/BG membranes
was observed until 28 days of culture. Signiﬁcantly higher
cell content was found in BG containing membranes seeded
with hBMSC after 28 days of culture. Complementarily, cell
metabolic activity was measured. As the values between dif-
ferent days for ﬂuorescence intensity of AlamarBlue are not
comparable, it was calculated a ratio between the composite
and PDLLA membrane samples, in each time point – see Fig. 3b.
Therefore, values above 1 means higher metabolic activity
for samples with BG than the ones without BG. Average cell
growth and their metabolic activity was typically higher in the
PDLLA/BG group than in the PDLLA group, for hBMSC. PDLLA
and PDLLA/BG membranes cultured with hBMSCs and hPDL
were further studied using SEM – see Fig. 3c. After 3 days of cul-
ture, hPDL spread perfectly on the PDLLA/BG membranes (B3).
On day 28, there was a very dense extracellular matrix (ECM)
deposition for both hBMSC and hPDL on PDLLA/BG mem-
branes (B28 and D28), which hampered the distinction of the
cells morphology and the examination of surface roughness
in the material. Still at this time point, (C28) the adhesion of
hBMSC could be detected, either spread in an elongated shape,
polarized with lamellipodia (see (*) on inset image  of C28) or in
some cell agglomerates.
3.2.2.  Cell  differentiation  and  mineralization
Alkaline phosphatase activity was measured to assess the
osteogenic differentiation potential of the cells cultured in the
developed membranes. The results obtained from this assay
(Fig. 4a) were normalized by the DNA content measured for the
same sample. No detectable ALP activity could be seen during
the ﬁrst time points, being consistent with the undifferenti-
ated state of the cells. After day 14, and specially day 28, it
can be seen signiﬁcant ALP activity of the cells in the mem-
branes. At 28 days of culture, higher ALP activity was detected
for the composite membranes cultured with hBMSC, com-
pared to the pure PDLLA membranes and even to the control
group. In alignment with the ALP results, statistically signif-
icantly higher calcium content was found in the PDLLA/BG
membranes (Fig. 4b). Von Kossa staining allowed observing the
formation of mineralization nodules by hPDL on composite
membranes, after 28 days of culture (Fig. 4c). No nodule for-
mation was detected on PDLLA membranes (data not shown).
In fact, there was an increasing calcium deposition, over time
(21–28th day), statistically signiﬁcant for the hBMSC on com-
posite membranes.4.  Discussion
In this study, the incorporation of BG in PDLLA membranes
modiﬁed their physico-chemical and biological properties.
The asymmetric distribution of the BG particles along the
thickness in the composite membrane permitted to induce
a bioactive character in one of the sides of the membrane.
The incorporation of BG particles has been reported to play
an important role in polymer surface wettability [19].  Its intro-
duction in polymer matrices can modify both surface and bulk
properties of the composite, by enhancing both hydrophilicity
and water absorption [20]. The faster weight loss in the com-
posite membranes could be related to the slow dissolution of
the inorganic component. Such process is consistent with the
event of the formation of an apatite layer upon immersion in
SBF.
The mechanical properties of the membranes were not sig-
niﬁcantly compromised with the introduction of BG. Adequate
mechanical integrity is known as an important requirement
for membranes in guided tissue regeneration. To adapt the
desired shape and to support the stresses of the surround-
ing native tissue at the site of implantation, membranes
should be strong but ﬂexible [3].  Previous works reported also
a reduction of the strength upon reinforcement in compos-
ites of poly(-hydroxyesters) [21,22].  The behavior observed
in the membranes may be due to the increase in pore size
by introducing Bioglass® in the pure PDLLA matrix. Moreover,
water can affect strongly the molecular wettability and the
viscoelastic properties of poly(lactic acid) [23]. However, in the
membranes prepared in this work swelling was almost inexis-
tent and no signiﬁcant plasticization effect of water took place,
as reﬂected in the tensile mechanical properties at 37 ◦C.
The inorganic component had a positive impact in the
adhesion, proliferation, differentiation and mineralization of
hBMSC on PDLLA/BG membranes. The enhanced hBMSC pro-
liferation and metabolic activity showed is in accordance with
some previous studies [24–26] that reported the promotion
of cell proliferation by Si and other released products from
bioactive glasses. Sun et al. showed an enhanced metabolic
activity of hBMSC on akermite ceramics veriﬁed using Alamar-
Blue staining, which has a composition very similar to BG [27].
Other studies [28–32] reported the enhancement of osteoblast
cell proliferation by the inﬂuence of BG particles corroborating
the results herein obtained for PDLLA/BG membranes, using
hBMSC. Higher concentrations of DNA were observed in BMSC
cultured when 45S5 Bioglass® was added to a new ceramic
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Fig. 3 – Results obtained from DNA and AlamarBlue assays at 1, 3, 7, 14 and 28 days of culture. (a) DNA content, in ng/mL, of
hBMSC and hPDL cells seeded onto each membrane type and controls (plastic cell culture in polystyrene). (b) Metabolic
activity ratio between the samples with and without BG (solid lines) for both cell types, where the border line (dashed light
gray line) is y = 1. Values are reported as mean ± SD (n = 3). (**) shows signiﬁcant differences for p < 0.01 and (***) for p < 0.001.
(c) SEM micrographs of PDLLA and PDLLA/BG membranes after cultured with hPDL and hBMSC cells. The subscripts indicate
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Phe incubation time.
ased on hydroxyapatite compared to the pure material [33].
igh contents of bioactive component may lead to a negative
ffect on cell behavior. For example, cell studies with scaffolds
f PDLLA, containing different contents of BG (5 and 40 wt%)
howed enhanced proliferation and ALP activity for the 5%
nes [34]. Due to the subsequent augmented and prolonged
on release and increase of pH, the materials with the largest
G concentration appeared to fail. Exceptions have been also
eported. For example, Helen et al. obtained better results with
DLLA/BG 30 wt%  comparing to 0 or even 5 wt% [35]. Thus italerts to the need of an ideal polymer/BG particles proportion
in order to achieve the pretended results. Many  studies have
examined the ability of BG to enhance not just cell prolifera-
tion [36,37] but also the extracellular matrix (ECM) production
[38], which is in accordance with the results achieved in this
study. Once that osteoblasts mature and start depositing ECM,
this production of ECM is a signal of cell differentiation [39].
While some authors [24,25] claim that the addition of BG
particles has no effect on ALP activity of rat primary cul-
ture osteoblasts and murine osteoblasts, others state that this
434  d e n t a l m a t e r i a l s 2 9 ( 2 0 1 3 ) 427–436
Fig. 4 – (a) Alkaline phosphatase activity, normalized by the DNA content, of hBMSC and hPDL cells on PDLLA and PDLLA/BG
membranes and controls (plastic cell culture in polystyrene) at 1, 3, 7, 14 and 28 days of culture. Values are reported as
mean ± SD (n = 3). (*) shows signiﬁcant differences for p < 0.1, (**) for p < 0.01 and (***) for p < 0.001 and evaluation of the
mineralization of hBMSC and hPDL cells on PDLLA and PDLLA/BG membranes and controls (plastic cell culture in
polystyrene), after 21 and 28 days of culture. (b) Calcium content quantiﬁcation and comparison between 21 and 28 days of
incubation. (c) Calcium nodules formation, veriﬁed by Von Kossa staining at day 28 of incubation, on PDLLA/BG membrane
cultured with hPDL cells. (d) Ratio of mineralization between seeded and bare membranes. Values are reported as
 (**) fmean ± SD (n = 3). (*) shows signiﬁcant differences for p < 0.1,
addition has stimulatory effects on the ALP activity of human
primary osteoblasts [40], BAF cells [35,41] and hBMSC [27]. This
provides a clear indication of a more  extended osteogenic
differentiation of hBMSC on the PDLLA/BG composite mem-
branes.
Calcium content and Von Kossa results were favorable to
the composite membranes, results which are in accordance
with other related studies. For example, a stronger and earlier
calcium phosphate mineral formation in bioactive compos-
ites was observed for rat bone marrow cells [42]; faster nodule
formation in porous bioactive glass scaffolds, as compared
with control cultures [26] using human primary osteoblasts,or p < 0.01 and (***) for p < 0.001.
among others previous studies [43,44],  demonstrating that
BG causes an increase of calcium in the medium, which is a
modulator of intracellular events. Bone nodules consist of dif-
ferentiated osteoblasts, extracellular matrix, and associated
minerals, and their formation characterizes a late stage of
osteoblast differentiation [45], being a good index of osteogen-
esis in vitro [45–47].  Both of the mineralization assays indicated
that BG improved mineralization, complementing each other
information.Therefore, our results suggest that the obtained asymmet-
ric bioactive PDLLA/BG 80/20 membrane, with osteoconduc-
tive properties in just one of the faces, could have potential
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se in the regeneration of distinct tissues, namely periodontal
igament and bone.
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